Skip to main content
ARTELO BIOSCIENCES, INC. logo

ARTELO BIOSCIENCES, INC. — Investor Relations & Filings

Ticker · ARTL ISIN · US04301G7060 US Manufacturing
Open in API
Filings indexed 422 across all filing types
Latest filing 2020-02-03 Regulatory Filings
Country US United States of America
Listing US ARTL

About ARTELO BIOSCIENCES, INC.

https://artelobio.com/

Artelo Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapeutics. The company's scientific approach is centered on modifying lipid-signaling pathways, particularly by modulating the endocannabinoid system. Its primary therapeutic focus is on developing improved treatments for patients with cancer and other serious diseases. Artelo is advancing a diverse portfolio of drug candidates through its development pipeline to address unmet medical needs.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2020
Regulatory Filings Classification · 100% confidence The document is a letter addressed to the U.S. Securities and Exchange Commission requesting acceleration of effectiveness for a Registration Statement on Form S-3. It references the filing and requests the SEC to declare it effective at a specified date and time. The document is short (2869 characters) and is a formal request related to a regulatory filing, not the filing itself or a financial report. It does not contain financial data or report content but is a procedural communication. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2020-02-03 English
Regulatory Filings 2020
Regulatory Filings
2020-01-21 English
FORM S-3
Capital/Financing Update Classification · 95% confidence The document is a Form S-3 Registration Statement filed with the U.S. Securities and Exchange Commission (SEC). It is a registration statement under the Securities Act of 1933 used by companies to register securities for public offering. The text includes details about the registrant, the securities to be offered, the registration fee, and disclaimers about the offering. It is not a financial report, earnings release, or management discussion, but rather a capital markets filing related to fundraising and securities issuance. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is the actual registration statement, not just an announcement of a report, so it is not RPA or RNS. Hence, the correct classification is CAP with high confidence.
2020-01-15 English
FORM S-8
Share Issue/Capital Change Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as equity incentive plans. It includes details about the securities to be registered, indemnification provisions, and references to other filings but does not contain financial statements or earnings data. Form S-8 is a capital markets filing related to share issuance under employee plans, not a financial report or earnings release. Therefore, it fits best under the category of Share Issue/Capital Change (SHA). The document length is substantial and contains detailed registration information, confirming it is not a mere announcement or certification.
2020-01-15 English
FORM 10-Q
Interim / Quarterly Report Q1 2020
2020-01-14 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text specifically mentions "Item 2.02 Results of Operations and Financial Condition" and states that the company issued a press release reporting financial results for the quarter ended November 30, 2019. It also notes that the press release is furnished as an exhibit. The document itself does not contain detailed financial statements or substantive financial data but rather announces the release of such information. The document length is 3224 characters, which is relatively short and consistent with an announcement rather than a full financial report. Therefore, this filing is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings and announcements that do not fit other specific categories like Earnings Release or Interim Report. The confidence in this classification is high given the clear identification of the document as a Form 8-K current report announcing financial results via a press release.
2020-01-14 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.